nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—SLC22A1—Metformin—polycystic ovary syndrome	0.0764	1	CbGbCtD
Midazolam—Brotizolam—PTAFR—polycystic ovary syndrome	0.0534	1	CrCbGaD
Midazolam—CYP4B1—adrenal cortex—polycystic ovary syndrome	0.0147	0.0479	CbGeAlD
Midazolam—CYP4B1—endometrium—polycystic ovary syndrome	0.0132	0.0428	CbGeAlD
Midazolam—CYP2E1—urine—polycystic ovary syndrome	0.0129	0.0419	CbGeAlD
Midazolam—CYP4B1—uterus—polycystic ovary syndrome	0.0121	0.0394	CbGeAlD
Midazolam—CYP4B1—pituitary gland—polycystic ovary syndrome	0.0119	0.0387	CbGeAlD
Midazolam—CYP4B1—adipose tissue—polycystic ovary syndrome	0.0119	0.0385	CbGeAlD
Midazolam—CYP4B1—adrenal gland—polycystic ovary syndrome	0.0106	0.0346	CbGeAlD
Midazolam—CYP3A4—urine—polycystic ovary syndrome	0.0104	0.0337	CbGeAlD
Midazolam—CYP4B1—female gonad—polycystic ovary syndrome	0.00992	0.0322	CbGeAlD
Midazolam—CYP4B1—vagina—polycystic ovary syndrome	0.00986	0.032	CbGeAlD
Midazolam—GABRG3—pituitary gland—polycystic ovary syndrome	0.00968	0.0315	CbGeAlD
Midazolam—UGT1A4—endocrine gland—polycystic ovary syndrome	0.00935	0.0304	CbGeAlD
Midazolam—GABRB1—pituitary gland—polycystic ovary syndrome	0.00748	0.0243	CbGeAlD
Midazolam—GABRP—endometrium—polycystic ovary syndrome	0.00741	0.0241	CbGeAlD
Midazolam—GABRP—uterus—polycystic ovary syndrome	0.00683	0.0222	CbGeAlD
Midazolam—GABRA4—pituitary gland—polycystic ovary syndrome	0.00675	0.0219	CbGeAlD
Midazolam—GABRP—pituitary gland—polycystic ovary syndrome	0.0067	0.0218	CbGeAlD
Midazolam—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00651	0.0212	CbGeAlD
Midazolam—GABRB1—vagina—polycystic ovary syndrome	0.0062	0.0201	CbGeAlD
Midazolam—GABRE—endometrium—polycystic ovary syndrome	0.00565	0.0184	CbGeAlD
Midazolam—GABRG2—pituitary gland—polycystic ovary syndrome	0.00565	0.0184	CbGeAlD
Midazolam—GABRP—vagina—polycystic ovary syndrome	0.00555	0.018	CbGeAlD
Midazolam—Toothache—Metformin—polycystic ovary syndrome	0.00553	0.0894	CcSEcCtD
Midazolam—GABRA3—endocrine gland—polycystic ovary syndrome	0.00537	0.0174	CbGeAlD
Midazolam—GABRA2—adipose tissue—polycystic ovary syndrome	0.00514	0.0167	CbGeAlD
Midazolam—GABRE—pituitary gland—polycystic ovary syndrome	0.00512	0.0166	CbGeAlD
Midazolam—GABRE—adipose tissue—polycystic ovary syndrome	0.0051	0.0166	CbGeAlD
Midazolam—SLC22A1—adipose tissue—polycystic ovary syndrome	0.00485	0.0158	CbGeAlD
Midazolam—GABRA2—adrenal gland—polycystic ovary syndrome	0.00461	0.015	CbGeAlD
Midazolam—GABRE—adrenal gland—polycystic ovary syndrome	0.00457	0.0149	CbGeAlD
Midazolam—GABRB3—pituitary gland—polycystic ovary syndrome	0.00434	0.0141	CbGeAlD
Midazolam—GABRA2—vagina—polycystic ovary syndrome	0.00427	0.0139	CbGeAlD
Midazolam—GABRE—female gonad—polycystic ovary syndrome	0.00426	0.0139	CbGeAlD
Midazolam—GABRE—vagina—polycystic ovary syndrome	0.00424	0.0138	CbGeAlD
Midazolam—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00415	0.0671	CcSEcCtD
Midazolam—SLC22A1—vagina—polycystic ovary syndrome	0.00403	0.0131	CbGeAlD
Midazolam—SLC22A1—endocrine gland—polycystic ovary syndrome	0.00377	0.0123	CbGeAlD
Midazolam—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00364	0.0118	CbGeAlD
Midazolam—GABRB3—endocrine gland—polycystic ovary syndrome	0.00336	0.0109	CbGeAlD
Midazolam—Lightheadedness—Metformin—polycystic ovary syndrome	0.00301	0.0487	CcSEcCtD
Midazolam—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00295	0.00958	CbGeAlD
Midazolam—Injury—Metformin—polycystic ovary syndrome	0.00266	0.043	CcSEcCtD
Midazolam—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00263	0.00854	CbGeAlD
Midazolam—Lethargy—Metformin—polycystic ovary syndrome	0.00249	0.0403	CcSEcCtD
Midazolam—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00247	0.00801	CbGeAlD
Midazolam—CYP3A5—female gonad—polycystic ovary syndrome	0.00246	0.00801	CbGeAlD
Midazolam—CYP3A5—vagina—polycystic ovary syndrome	0.00245	0.00796	CbGeAlD
Midazolam—CYP2B6—vagina—polycystic ovary syndrome	0.00243	0.00791	CbGeAlD
Midazolam—ABCB1—embryo—polycystic ovary syndrome	0.00237	0.00771	CbGeAlD
Midazolam—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00229	0.00745	CbGeAlD
Midazolam—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00228	0.0074	CbGeAlD
Midazolam—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00218	0.0353	CcSEcCtD
Midazolam—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00214	0.00695	CbGeAlD
Midazolam—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00195	0.00632	CbGeAlD
Midazolam—Drowsiness—Metformin—polycystic ovary syndrome	0.00188	0.0304	CcSEcCtD
Midazolam—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00184	0.0298	CcSEcCtD
Midazolam—ABCB1—endometrium—polycystic ovary syndrome	0.00174	0.00564	CbGeAlD
Midazolam—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00172	0.00559	CbGeAlD
Midazolam—Bradycardia—Metformin—polycystic ovary syndrome	0.00172	0.0278	CcSEcCtD
Midazolam—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00166	0.0268	CcSEcCtD
Midazolam—ABCB1—uterus—polycystic ovary syndrome	0.0016	0.0052	CbGeAlD
Midazolam—Eye disorder—Metformin—polycystic ovary syndrome	0.00158	0.0255	CcSEcCtD
Midazolam—ABCB1—pituitary gland—polycystic ovary syndrome	0.00157	0.00511	CbGeAlD
Midazolam—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00157	0.0254	CcSEcCtD
Midazolam—ABCB1—adipose tissue—polycystic ovary syndrome	0.00157	0.00509	CbGeAlD
Midazolam—Immune system disorder—Metformin—polycystic ovary syndrome	0.00153	0.0247	CcSEcCtD
Midazolam—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00152	0.0246	CcSEcCtD
Midazolam—Chills—Metformin—polycystic ovary syndrome	0.00152	0.0245	CcSEcCtD
Midazolam—Erythema—Metformin—polycystic ovary syndrome	0.00147	0.0238	CcSEcCtD
Midazolam—ABCB1—adrenal gland—polycystic ovary syndrome	0.0014	0.00456	CbGeAlD
Midazolam—Vision blurred—Metformin—polycystic ovary syndrome	0.00139	0.0224	CcSEcCtD
Midazolam—Tremor—Metformin—polycystic ovary syndrome	0.00138	0.0223	CcSEcCtD
Midazolam—Syncope—Metformin—polycystic ovary syndrome	0.00132	0.0213	CcSEcCtD
Midazolam—ABCB1—female gonad—polycystic ovary syndrome	0.00131	0.00425	CbGeAlD
Midazolam—ABCB1—vagina—polycystic ovary syndrome	0.0013	0.00423	CbGeAlD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00124	0.0201	CcSEcCtD
Midazolam—ABCB1—endocrine gland—polycystic ovary syndrome	0.00122	0.00396	CbGeAlD
Midazolam—Shock—Metformin—polycystic ovary syndrome	0.00118	0.0191	CcSEcCtD
Midazolam—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00118	0.019	CcSEcCtD
Midazolam—Skin disorder—Metformin—polycystic ovary syndrome	0.00117	0.0189	CcSEcCtD
Midazolam—Hypotension—Metformin—polycystic ovary syndrome	0.00112	0.0181	CcSEcCtD
Midazolam—Paraesthesia—Metformin—polycystic ovary syndrome	0.00108	0.0174	CcSEcCtD
Midazolam—Dyspnoea—Metformin—polycystic ovary syndrome	0.00107	0.0173	CcSEcCtD
Midazolam—Somnolence—Metformin—polycystic ovary syndrome	0.00107	0.0173	CcSEcCtD
Midazolam—Dyspepsia—Metformin—polycystic ovary syndrome	0.00106	0.0171	CcSEcCtD
Midazolam—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00104	0.0168	CcSEcCtD
Midazolam—Fatigue—Metformin—polycystic ovary syndrome	0.00103	0.0167	CcSEcCtD
Midazolam—Constipation—Metformin—polycystic ovary syndrome	0.00103	0.0166	CcSEcCtD
Midazolam—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000989	0.016	CcSEcCtD
Midazolam—Urticaria—Metformin—polycystic ovary syndrome	0.000953	0.0154	CcSEcCtD
Midazolam—Asthenia—Metformin—polycystic ovary syndrome	0.000861	0.0139	CcSEcCtD
Midazolam—Pruritus—Metformin—polycystic ovary syndrome	0.000849	0.0137	CcSEcCtD
Midazolam—Dizziness—Metformin—polycystic ovary syndrome	0.000793	0.0128	CcSEcCtD
Midazolam—Vomiting—Metformin—polycystic ovary syndrome	0.000763	0.0123	CcSEcCtD
Midazolam—Rash—Metformin—polycystic ovary syndrome	0.000756	0.0122	CcSEcCtD
Midazolam—Dermatitis—Metformin—polycystic ovary syndrome	0.000756	0.0122	CcSEcCtD
Midazolam—Headache—Metformin—polycystic ovary syndrome	0.000752	0.0122	CcSEcCtD
Midazolam—Nausea—Metformin—polycystic ovary syndrome	0.000713	0.0115	CcSEcCtD
Midazolam—CYP4B1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000189	0.000377	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000188	0.000375	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000186	0.000372	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000185	0.000369	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000184	0.000368	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—POMC—polycystic ovary syndrome	0.000184	0.000367	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000184	0.000367	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000183	0.000366	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000183	0.000366	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00018	0.00036	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.00018	0.00036	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.00018	0.000359	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.00018	0.000359	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000178	0.000356	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PNPLA2—polycystic ovary syndrome	0.000178	0.000355	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000176	0.000351	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—MTHFR—polycystic ovary syndrome	0.000176	0.000351	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000176	0.000351	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000176	0.000351	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000175	0.000349	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000175	0.000349	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000173	0.000346	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000172	0.000343	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000172	0.000343	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000171	0.000341	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SRD5A1—polycystic ovary syndrome	0.000168	0.000336	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000168	0.000335	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000165	0.00033	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000163	0.000326	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	0.000161	0.000321	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TH—polycystic ovary syndrome	0.00016	0.00032	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00016	0.000319	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000159	0.000317	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000157	0.000314	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TEAD2—polycystic ovary syndrome	0.000157	0.000313	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000157	0.000313	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000157	0.000313	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000156	0.000311	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.000153	0.000307	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000153	0.000307	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000153	0.000306	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000153	0.000306	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—STAR—polycystic ovary syndrome	0.000149	0.000298	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000149	0.000298	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000146	0.000293	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000146	0.000292	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000146	0.000292	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000146	0.000292	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.000143	0.000286	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PPARG—polycystic ovary syndrome	0.000143	0.000285	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—POMC—polycystic ovary syndrome	0.000141	0.000281	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—INS—polycystic ovary syndrome	0.00014	0.000279	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000139	0.000277	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000137	0.000274	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000137	0.000273	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000136	0.000271	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HMMR—polycystic ovary syndrome	0.000133	0.000266	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000131	0.000262	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GNAS—polycystic ovary syndrome	0.000131	0.000261	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000129	0.000257	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000128	0.000256	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000127	0.000254	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000127	0.000253	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000125	0.00025	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000124	0.000249	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000124	0.000249	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NCOR1—polycystic ovary syndrome	0.000124	0.000248	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000122	0.000243	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000122	0.000243	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000122	0.000243	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00012	0.000239	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	0.000119	0.000237	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000118	0.000236	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000118	0.000235	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000116	0.000232	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000116	0.000232	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—LHB—polycystic ovary syndrome	0.000116	0.000231	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000116	0.000231	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000116	0.000231	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000113	0.000226	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000112	0.000224	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00011	0.000221	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—MTHFR—polycystic ovary syndrome	0.00011	0.00022	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00011	0.000219	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.000108	0.000217	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	0.000106	0.000211	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.000105	0.00021	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000105	0.000209	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000104	0.000207	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000103	0.000207	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000103	0.000206	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	0.000101	0.000202	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000101	0.000202	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000101	0.000202	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	9.89e-05	0.000198	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	9.87e-05	0.000197	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	9.85e-05	0.000197	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—RRM2—polycystic ovary syndrome	9.78e-05	0.000195	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	9.73e-05	0.000194	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	9.68e-05	0.000193	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	9.61e-05	0.000192	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	9.57e-05	0.000191	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—YAP1—polycystic ovary syndrome	9.42e-05	0.000188	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	9.21e-05	0.000184	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	9.18e-05	0.000183	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	9.07e-05	0.000181	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NAMPT—polycystic ovary syndrome	9.05e-05	0.000181	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	9.02e-05	0.00018	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.01e-05	0.00018	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.01e-05	0.00018	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	9e-05	0.00018	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	9e-05	0.00018	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP11A1—polycystic ovary syndrome	8.94e-05	0.000179	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	8.93e-05	0.000178	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PPARG—polycystic ovary syndrome	8.92e-05	0.000178	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	8.81e-05	0.000176	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	8.8e-05	0.000176	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—POMC—polycystic ovary syndrome	8.79e-05	0.000176	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—STAR—polycystic ovary syndrome	8.76e-05	0.000175	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	8.76e-05	0.000175	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—INS—polycystic ovary syndrome	8.75e-05	0.000175	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	8.72e-05	0.000174	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	8.54e-05	0.00017	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	8.52e-05	0.00017	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	8.44e-05	0.000169	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.37e-05	0.000167	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8.35e-05	0.000167	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	8.31e-05	0.000166	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	8.02e-05	0.00016	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	7.86e-05	0.000157	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	7.84e-05	0.000157	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	7.83e-05	0.000156	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	7.81e-05	0.000156	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	7.77e-05	0.000155	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TH—polycystic ovary syndrome	7.73e-05	0.000154	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	7.61e-05	0.000152	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	7.59e-05	0.000152	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	7.52e-05	0.00015	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	7.49e-05	0.00015	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	7.45e-05	0.000149	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.35e-05	0.000147	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	7.33e-05	0.000146	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	7.32e-05	0.000146	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	7.19e-05	0.000144	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TH—polycystic ovary syndrome	7.19e-05	0.000144	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.12e-05	0.000142	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.12e-05	0.000142	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	7.1e-05	0.000142	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	7.07e-05	0.000141	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	7.05e-05	0.000141	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	7.03e-05	0.00014	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	7e-05	0.00014	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	6.96e-05	0.000139	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	6.94e-05	0.000139	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—LHB—polycystic ovary syndrome	6.79e-05	0.000136	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	6.71e-05	0.000134	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	6.64e-05	0.000133	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	6.61e-05	0.000132	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	6.58e-05	0.000131	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	6.57e-05	0.000131	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	6.56e-05	0.000131	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	6.47e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	6.46e-05	0.000129	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	6.43e-05	0.000128	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	6.31e-05	0.000126	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	6.01e-05	0.00012	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.97e-05	0.000119	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	5.92e-05	0.000118	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	5.87e-05	0.000117	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	5.73e-05	0.000114	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TH—polycystic ovary syndrome	5.72e-05	0.000114	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	5.7e-05	0.000114	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.66e-05	0.000113	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TH—polycystic ovary syndrome	5.6e-05	0.000112	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	5.59e-05	0.000112	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TH—polycystic ovary syndrome	5.59e-05	0.000112	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	5.56e-05	0.000111	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	5.52e-05	0.00011	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	5.45e-05	0.000109	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	5.43e-05	0.000109	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.4e-05	0.000108	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	5.31e-05	0.000106	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	5.31e-05	0.000106	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	5.3e-05	0.000106	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	5.24e-05	0.000105	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	5.23e-05	0.000104	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	5.12e-05	0.000102	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	5.11e-05	0.000102	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	4.95e-05	9.88e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	4.94e-05	9.87e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	4.87e-05	9.73e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.81e-05	9.61e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	4.67e-05	9.32e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.59e-05	9.16e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	4.57e-05	9.13e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.56e-05	9.11e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	4.44e-05	8.88e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	4.35e-05	8.69e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	4.34e-05	8.68e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	4.31e-05	8.6e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	4.25e-05	8.48e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—INS—polycystic ovary syndrome	4.22e-05	8.44e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TH—polycystic ovary syndrome	4.22e-05	8.42e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	4.21e-05	8.42e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.18e-05	8.36e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	4.13e-05	8.24e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	4.12e-05	8.23e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	4.1e-05	8.19e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.09e-05	8.17e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	4.01e-05	8.01e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.96e-05	7.91e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	3.95e-05	7.9e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—INS—polycystic ovary syndrome	3.93e-05	7.85e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	3.93e-05	7.85e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.86e-05	7.7e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	3.85e-05	7.68e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.84e-05	7.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.64e-05	7.28e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.53e-05	7.05e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	3.44e-05	6.87e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.4e-05	6.8e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	3.28e-05	6.55e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.27e-05	6.53e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.23e-05	6.45e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	3.19e-05	6.36e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	3.14e-05	6.27e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—INS—polycystic ovary syndrome	3.12e-05	6.24e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	3.12e-05	6.23e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	3.11e-05	6.22e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	3.11e-05	6.21e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	3.08e-05	6.15e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	3.07e-05	6.13e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—INS—polycystic ovary syndrome	3.06e-05	6.11e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—INS—polycystic ovary syndrome	3.05e-05	6.1e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.05e-05	6.09e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3e-05	5.99e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.9e-05	5.79e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.6e-05	5.19e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.53e-05	5.05e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.38e-05	4.74e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.35e-05	4.69e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.32e-05	4.63e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.3e-05	4.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.12e-05	4.23e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.02e-05	4.03e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.91e-05	3.82e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.78e-05	3.57e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.45e-05	2.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.43e-05	2.85e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.42e-05	2.84e-05	CbGpPWpGaD
